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Abstract
Background: Patients with systemic sclerosis may develop mild abnormalities of liver function
tests. More serious hepatic involvement has been well documented but is rare. Idiopathic portal
hypertension had been reported only in a few female patients with systemic sclerosis.
Case presentation: An 82-year-old man with known systemic sclerosis presented with melaena.
Urgent gastroscopy revealed oesophageal varices, which re-started bleeding during the procedure
and were treated ensocopically, with Sengstaken tube and glypressin. Liver function tests and
coagulation were normal. Non-invasive liver screen (including hepatitis viral serology and
autoantibodies) was negative. Ultrasound scan of the abdomen revealed a small liver with coarse
texture and no focal lesion. Hepato-portal flow was demonstrated in the portal vein. The spleen
was enlarged. A moderate amount of free peritoneal fluid was present. A CT scan confirmed the
absence of portal vein thrombosis. One month following discharge the patient had a liver biopsy.
Histological examination showed essentially normal liver tissue; there was no evidence of any
excess inflammation and no features to suggest cirrhosis or drug-induced liver disease. Taking into
account the above evaluation we concluded that the patient had idiopathic portal hypertension.
Conclusion: Both male and female patients with systemic sclerosis may – rarely – develop
idiopathic portal hypertension.
Background
Systemic sclerosis (SSc) is a multisystem disease of
unknown cause. The incidence of the disease is 10/mil-
lion population per year. The female/male ratio is 4:1. A
few cases of idiopathic portal hypertension (IPH) associ-
ated with SSc have been reported, all in females.
Case presentation
We report a case of an 82-year-old man admitted to the
hospital with melaena and dizziness on standing.
He had a past medical history of SSc diagnosed 3 years
before and pulmonary fibrosis. He was on prednisolone
and azathioprine. There was no history of liver disease or
alcohol abuse.
Published: 26 May 2005
BMC Gastroenterology 2005, 5:16 doi:10.1186/1471-230X-5-16
Received: 15 December 2004
Accepted: 26 May 2005
This article is available from: http://www.biomedcentral.com/1471-230X/5/16
© 2005 Moschos et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Gastroenterology 2005, 5:16 http://www.biomedcentral.com/1471-230X/5/16
Page 2 of 3
(page number not for citation purposes)
On examination his blood pressure of 95/65 mmHg,
pulse 90/min. He had bilateral fine inspiratory crackles.
The abdomen was soft and non-tender. Rectal examina-
tion revealed melaena.
White blood count was 12,700/mm3, haemoglobin 10.9
g/dl, platelets 186,000/mm3 and MCV 99.4 fl. Blood urea
was 12.5 mmol/l, creatinine 68 µmol/l, electrolytes were
normal, glucose 6.3 mmol/l. Serum alanine aminotrans-
ferase was 12 u/l, bilirubin 12 µmol/l, γ -glutamyl trans-
ferase 54 u/l, alkaline phosphatase 35 u/l, total protein 52
g/l, albumin 27 g/l and C-reactive protein 12. Coagulation
studies were normal. Factor V Leiden mutation was not
present. Hepatitis viral serology and autoantibody screen
were negative and α -1-antitrypsin was normal. Ferritin
was 103 µmol/l, caeruloplasmin was 0.25 µmol/l and α -
fetoprotein was 0.9 kU/L.
Urgent gastroscopy revealed oesophageal varices, fresh
blood and clots in the stomach. During the procedure the
oesophageal varices started bleeding. Haemostasis was
not achieved despite sclerotherapy and therefore a Seng-
staken tube was inserted. The patient was admitted to the
High Dependency Unit and commenced on intravenous
glypressin, antibiotics and was transfused four units of
blood. The following day a repeat gastroscopy showed
two columns of grade II oesophageal varices, two
oesophageal ulcers (probably secondary to sclerotherapy)
and mild portal gastropathy.
Ultrasound scan of the abdomen revealed a small liver
with coarse texture and no focal lesion. Hepato-portal
flow was demonstrated in the portal vein. The common
bile duct was of normal caliber. The spleen was enlarged
(bipolar length 12.8 cm). A moderate amount of free peri-
toneal fluid was noted. CT scan confirmed the absence of
portal vein thrombosis.
The patient was discharged three weeks following admis-
sion on propranolol 40 mg twice daily, azathioprine 50
mg twice daily, spironolactone 100 mg once daily, pred-
nisolone 7.5 mg once daily, lansoprazole, vitamin D and
calcium. He had two further endoscopies, one and five
weeks following discharge and his varices were success-
fully treated with banding. One month following dis-
charge he had a liver biopsy. There was no evidence of any
excess inflammation and no features to suggest cirrhosis
or drug-induced liver disease. Overall this was essentially
normal liver tissue.
Taking into account the liver histology and the absence of
evidence of portal vein thrombosis on imaging we con-
cluded that the patient had IPH. We decided not to pro-
ceed to portal pressure measurement because this would
not contribute to the management of the patient.
Two months following discharge the patient was reviewed
and was well. He had not had any further episodes of hae-
matemesis or melaena. He had normal full blood count
and biochemistry results.
Conclusion
Abnormalities of liver function occur frequently in
patients with rheumatic conditions. Although benign
extra-articular manifestations of rheumatic disease are the
most common ones, more serious hepatic involvement,
including hepatic steatosis, vasculitis, nodular regenera-
tive hyperplasia and primary biliary cirrhosis, portal vein
obliteration and portal hypertension and rarely portal
fibrosis with abnormal lobular architecture have been
observed in rheumatic diseases. Vascular disorders of the
liver also have been described, such as Budd-Chiari syn-
drome [1]. The medical management of rheumatic disease
involves potentially hepatotoxic medications. Occult hep-
atitis C infection and associated cryoglobulinaemia can
mimic rheumatic disease and antiviral therapy may be
beneficial [2].
IPH is frequently associated with autoimmune diseases in
Japan. In a large survey by questionnaire 12% of patients
with IPH had one or two autoimmune diseases and a
quarter of them had hyperglobulimaemia [3]. This data
raise the possibility of causal rather than an incidental
association between IPH and autoimmune disorders. An
immunological basis for IPH pathogenesis has been sug-
gested by Terada et al in Japan; the smaller venous radicles
in the small and medium-sized portal tracts may be targets
of immunologic attack in IPH [4].
Liver involvement in patients with SSc has been well doc-
umented but is rare. In a post-mortem series of 57 SSc
patients histological liver damage was found in 8.8% of
cases [5].
There are only a few reported cases of SSc with IPH, and
all have been females [6-8]. Our case is the first male
patient reported with SSc and IPH.
When causes of portal hypertension like cirrhosis, extra-
hepatic portal vein obstruction, and infections like Schis-
tosomiasis have been excluded, there remains a group of
patients with portal hypertension of uncertain aetiology.
These patients have good parenchymal reserve and much
better survival than patients with portal hypertension
caused by cirrhosis. Infection or exposure to several envi-
ronmental toxins such as arsenic has been suspected as a
cause but not proven.
There is a striking geographic variability in incidence and
manifestations of IPH. In the United States, the sex inci-
dence is nearly equal and the patients are generally abovePublish with BioMed Central    and   every 
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50 years old, with gastrointestinal bleeding being the
usual presentation. Liver function tests are normal and
anaemia and leucopoenia are frequent. IPH is more com-
mon in India and Japan [9,10]. The largest study from
India [9] observed female preponderance (62% female);
mean age of presentation was 31 years. The majority of
patients in this study presented with self-felt abdominal
mass (splenomegaly) and / or gastrointestinal bleeding.
In Japan 75% of patients are female, and the mean age of
presentation is 36 years. In these patients gastrointestinal
bleeding, splenomegaly, or anaemia are equally frequent.
The liver may look nodular, but this nodularity is usually
relatively superficial. The nodules are similar to those seen
in nodular regenerative hyperplasia. Nodularity is more
pronounced in the cases from India. Cirrhosis by defini-
tion is not present, but there is usually significant fibrosis
along the portal vein and its branches particularly near the
hilus. However this is difficult to be recognized by liver
biopsy. The portal vein usually has a thick sclerotic wall
and there may be concentric fibrosis in the portal areas in
the advanced cases. There may be diminution or oblitera-
tion of portal vein branches within the triads. Inflamma-
tion and necrosis are not prominent features of this
condition. Portal vein thrombosis can occur, but this is a
complication rather than a cause of IPH since it usually
occurs later in the course of well-established disease.
In conclusion, clinicians should be aware of the rare asso-
ciation of systemic sclerosis and idiopathic portal hypert-
ention, which may develop even in male patients.
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